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Orphan receptors belong to the nuclear receptor superfamily of liganded 
transcription factors, whose ligands either do not exist or remain to be identified. We 
report here the cloning and characterization of the novel avian orphan receptor TRR (for 
testis specific receptor 2 (TR2) related receptor). The TRR gene encodes a protein of 
569 amino acids which shows approximately 72% overall identity with TR2 and 95% 
identity in the DNA binding domain (DBD). The TRR gene is expressed in almost all 
adult tissues and embryonic stages examined unlike its mammalian relative TR2, which 
is specifically expressed in testis. Electrophoretic mobility shift assays demonstrate that 
TRR binds the canonical direct repeat DNA recognition sequences spaced by one, four 
and five nucleotides (DR1, DR4, DR5), and in consistence with the results with 
canonical DNA binding sequences, TRR forms specific DNA-protein complex with 
chicken phenobarbital response elements containing DR4 motifs. Both in vitro and in 
vivo interaction studies demonstrate that TRR forms homodimer. Finally, transient 
transfection studies reveal its capability to transactivate canonical DR1, DR4 and DR5 
sequences and the constitutive activity of TRR is mapped to the N-terminal region of 
this orphan receptor.  
 





The steroid/thyroid hormone receptor superfamily is a large group of related 
transcriptional factors that control cellular differentiation, development, and 
homeostasis by direct interaction with distinct cis-elements on their target genes. This 
superfamily includes receptors for steroids, thyroid hormone, vitamin D3, retinoids and 
a large number of orphan receptors whose cognate ligands either do not exist or are still 
unknown (1). These proteins are able to bind to specific DNA sequences named 
hormone response elements (HREs) associated with their target genes. Sequence 
analysis and functional studies reveal a modular structure for these proteins (2). The N-
terminal hypervariable region called A/B domain contains a ligand independent 
activation function AF-1 (activating function-1). The strongly conserved DNA binding 
domain (DBD), called C domain, is composed of two zinc finger motifs. The C-terminal 
ligand binding domain (LBD) is moderately conserved among different receptors. 
Distinct parts of this domain play essential roles in homodimerization, 
heterodimerization, and interaction with transcription cofactors affecting transcriptional 
activity (reviewed in 1, 2, 3). The LBD also contains an activation function 2 (AF-2) 
motif which  essentially exhibits ligand-dependent transactivation function in classical 
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nuclear hormone receptors. However, several orphan nuclear receptors including 
constitutively activated receptor (CAR) (4) and estrogen related receptor (ERR) (5) 
show constitutive activity of AF-2 in the absence of any added ligand.   
With the advent of current molecular biotechnology, a large number of nuclear 
receptors have been cloned from animals ranging from jelly fish to human. Although 
biological functions of most of the orphans are unknown, a large body of evidence, 
especially insights gained from gene targeting strategies, indicate very important roles 
for orphans. Disruption of ERR causes severe placental abnormality (6), and 
disruption of SF-1 in mice causes lack of adrenal glands and gonads with consequent 
male to female sex reversal of their internal and external genitalia  (reviewed in 7). 
Moreover, early embryonic lethality is associated with the homozygous loss of HNF4 
gene in mice, and loss of a single copy of HNF4 in human causes the MODY syndrome 
(maturity onset diabetes of the young) (8-10). 
The TR2 subfamily of nuclear hormone receptors mainly consists of two well 
characterized receptors named TR2 and TR4. These receptors and their several isoforms 
have been cloned from mouse, human, and rat (11-15). Moreover, amphibian members 
of this group of receptors, developmental receptor 1 (DOR1) and developmental 
receptor 2 (DOR2), have also been cloned from Ambystoma and Xenopus, respectively 
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(16, 17), although these amphibian forms are yet to be functionally characterized. The 
mammalian forms of TR2 are expressed at a high level in adult testis and particularly in 
the postmeiotic germ cells (11-14). Previous studies have demonstrated that TR2 is a 
potent repressor of retinoic acid (RA), thyroid hormone (T3) and vitamin D3 mediated 
transcriptional activity of their cognate receptors via competitive binding to the 
hormone response elements of DR series (18-25). However, a recent report also 
demonstrated a role of TR2 as an activator of RAR2 gene promoter where TR2 in 
association with CREM activates the gene (26).  
In the current study, we report the molecular cloning and characterization of a 
novel chicken orphan nuclear receptor TRR. TRR encodes a protein of 569 amino acids. 
Among the adult tissues examined, TRR mRNA is highly expressed in lung, testis, 
kidney, and small intestine whereas a lower level of expression is evident in skeletal 
muscle, heart, brain and liver. Expression of TRR mRNA in chick embryo is detected in 
all the stages examined including developing head and trunk segments. The DNA 
binding analysis showed significant binding activity of TRR on DR1, DR4 and DR5 
sequences, and in consistence with these DNA binding results TRR also forms a DNA-
Protein complex with a PBRU described previously as a specific response element for 
the chicken xenobiotic receptor (CXR) (27, 28). In vitro and in vivo interaction studies 
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revealed that TRR forms homodimers. Finally, transient transfection studies confirmed    
activation of  canonical DR1, DR4, and DR5 elements mediated by TRR and the 
molecular domain responsible for this activity was mapped to the N-terminal A/B 
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MATERIALS AND METHODS 
 
Isolation of TRR cDNA  
Chicken liver cDNA library (stratagene) was screened with the DNA binding 
domain of mouse constitutively activated receptor (CAR) as a probe using low 
stringency hybridization and washing conditions. Briefly, about 6x105 plaques were 
plated and immobilized on Hybond-N nylon membranes (Amersham Pharmacia 
Biotech). The hybridization was carried out at 550C in hybridization buffer (6XSSC, 
0.5% SDS, and 10X Denhardt’s solution without salmon sperm DNA. The membranes 
were washed 3 times (15 minutes each) at room temperature in 3XSSC, 0.1% SDS after 
40 hrs of hybridization and autoradiographed. Finally, positive clones were excised 
from the phage to the plasmid Bluescript using in vivo excision by the Exassist system 
supplied with the library, and sequenced by the dideoxy sequencing method.   
 
Plasmids 
 TRR cDNA was excised from the plasmid pBluescript and inserted into 
pcDNA3 mammalian expression vector at BamH1 and XhoI sites. A polymerase chain 
reaction (PCR) amplified fragment of the TRR LBD corresponding to amino acids 139-
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571 was cloned into EcoRI and XhoI sites of pL202PL and cgatrp (29) for the LexA and 
B42 fusion expressions in yeast. The mammalian two hybrid DNA constructs were 
cloned by inserting the same fragment into EcoRI and SalI sites of  pCMX-GAL4 and 
EcoRI and XhoI sites of pcDNA3-VP16 vectors. For the GAL4A/B domain construct, a 
PCR amplified product corresponding to the N-terminal 74 amino acids of TRR, 
containing an in-frame stop codon was cloned into EcoRI and SalI sites of a pCMX-
Gal4 vector. DR1, 4, and 5 driven luciferase reporter constructs were kind gifts from Dr. 
Jae Woon Lee. 
 
In vitro translation 
 TRR cDNA in pBluescript was transcribed and translated in vitro by using a 
coupled Rabbit reticulocyte system (TNT, Promega) in the presence of [35S] methionine 
(Amersham Pharmacia Biotech) according to the manufacturer’s instructions. The 
translated protein was analyzed on 10% SDS-polyacrylamide gel, and visualized by 
autoradiography. 
Northern blot analysis 
 30g of total RNA from the indicated tissues from an adult broiler breeder 
was isolated and Northern blot analysis was carried out as described previously (30). To 
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obtain RNA from the various stages of chick embryos, fertilized chick eggs were 
incubated at 38.50C in a humidified forced-draft incubator for 75-150 h. At the time of 
harvest, the embryos were staged according to Hamburger and Hamilton (31). The 
harvested embryos at the stages between 19-28 were washed several times in phosphate 
buffered saline (PBS), and quick frozen in dry ice-isopropanol bath and stored at -700C 
until use. Total RNA from the indicated stages was extracted and northern blot analysis 
was performed as described previously (30). 
 
Electrophoretic Mobility Shift Assay 
 Chicken CXR, chicken TRR and chicken 9-cis-retinoid X receptor gamma 
(RXR) were synthesized in vitro using the TNT T7 Quick Coupled 
Transcription/Translation System (Promega) according to the manufacturer's 
instructions. Probes were labeled and purified over a Biospin 30 Chromatography 
Column (Biorad). A volume of labeled oligonucleotide corresponding to 100'000 cpm 
was used for each reaction in 10 mM Tris (pH 8.0), 40 mM KCl, 0.05% NP-40, 6% 
glycerol, 1 mM dithiothreitol, 0.4 mg/ml BSA, 0.2 g poly(dI-dC and 2.5 l of each of 
the in vitro synthesized proteins as described previously (28). To test for supershifts, 0.5 
l of monoclonal anti-mouse-RXR rabbit antibody (kindly provided by Dr. P. Chambon, 
 - 12 - 
  
  
IGBMC, Université Louis Pasteur, Illkirch, France) was added to the reaction mix. In 
case of competitions unlabeled oligonucleotides at a 50 fold molar excess was used.  
 
Yeast two hybrid assays 
 Yeast two hybrid interaction studies were performed as previously described 
(32). Briefly, LexA TRR LBD was co-transformed with B42 vector alone or B42 fused 
receptor constructs into Saccharomyces cerevisae EGY48 containing the -
galactosidase reporter plasmid, 8H18-34, and the transformants were plated on plates 
containing the appropriate selection markers. The -galactosidase assay on plates were 
carried out as described previously (32). 
 
Cell culture and transient transfection 
 HeLa cells were seeded in 24-well plates 24 hours before transfection in the 
Dulbeccos Modified Eagle’s Medium (Life Technologies) supplemented with 10% fetal 
bovine serum and transfected with the indicated plasmids using Superfect (Qiagen), 
according to the manufacturer’s instructions. 48 hours after transfection, cells were 
harvested and luciferase activity was assayed as described previously (30). The 
luciferase activity was normalized with the -galactosidase activity. 






Identification of TRR cDNA  
  In order to find new members of orphan nuclear receptor superfamily, a chicken 
liver cDNA library was screened using a low stringency hybridization approach with the 
DBD of mouse constitutively active receptor (mCAR) cDNA as a probe. Among the 
positive clones selected three independent clones represented for a full length TRR. The 
complete nucleotide and deduced amino acid sequences were determined (fig.1A).  
The full-length TRR cDNA was found to consist of 2371 nucleotides. The open reading 
frame (ORF) starting from the first methionine to the first stop codon consisted of 1707 
nucleotides and encoded a protein containing 569 amino acids.  
The sequence analysis and subsequent blast searches revealed that TRR bears 
72% overall amino acid identity with TR2. The DBD showed 95% amino acid identity, 
whereas the DEF domains including the hinge region and LBD showed a sequence 
identity of 75%. The hypervariable A/B domain showed 40% amino acid identity (fig 
1B). A closer examination of TRR and its mammalian and amphibian relatives revealed 
that the first 19 amino acids were remarkably conserved in the hypervariable A/B 
 - 14 - 
  
  
domain, indicating that these 19 amino acids may play an essential role in the biological 
function of these receptors (fig. 2A). However, the minimal sequence implied in the 
activity of TR2, spanning from N-terminal amino acid number from 25 to 30 (26) were 
not found to be conserved in both TRR and its amphibian relative developmental orphan 
receptor 1 (DOR1). Moreover, the C-terminal region of the A/B domain containing 
amino acids 50 to 100, which had been implied for a masking effect on the N-terminal 
activation sequence of TR2 (26), were not found to exist in TRR (fig.2A). A closer 
examination of the C-terminal part of the LBD revealed that the heptad repeat region in 
the helix 10 of the LBD and the putative AF-2 motif of TR2 and TRR were almost 
identical, indicating that the co-activator binding and the dimerization properties of 
TRR might be very similar to TR2 (fig.2B). Taken together, these results suggest that 
TRR might be structurally and functionally different from TR2, although some of its 
properties like DNA binding specificity and interaction pattern with other proteins 
might be similar to TR2. 
 
Expression of TRR  
In order to determine the expression pattern of TRR in adult tissues, a Northern 
blot analysis was performed using the full length TRR cDNA as a probe. High 
 - 15 - 
  
  
expression of a 2.4 Kb TRR transcript was found in lung, testis, and kidney, and a lesser 
level of expression was observed in skeletal muscle, small intestine and heart, whereas 
very little expression was observed in liver and brain (fig. 3A). The tissue distribution of 
TRR shows a marked difference from its mammalian relatives, mouse, human and rat 
TR2s, which were shown to be expressed at a high level in testis only (11,12). This 
particular difference of expression pattern of TRR suggests a possibility that TRR may 
play a different role in chicken. As demonstrated in Fig. 3B, Northern blot analysis of an 
embryonic stage blot revealed that TRR gene is expressed in all the stages examined. 
However, a higher expression of TRR transcript was detected at stage 26 onwards, and 
the intensity of expression was equal in both stage 28 head and trunk segments 
indicating that TRR might be involved in overall development of chick embryo. The 
SDS-PAGE analysis of in vitro translated TRR revealed a protein of approximately 68 
kDa (Fig.3C) which is similar to the estimated size of TRR from its predicted amino 
acid sequence.  
 
DNA binding analysis of TRR  
To determine the DNA binding pattern of TRR, gel mobility shift assays were 
performed with the oligonucleotide probes ranging from DR0 to DR6. TRR was found 
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to form specific high affinity DNA-protein complexes with DR1, DR4 and consensus 
DR5 only (Fig. 4A). This finding was rather surprising considering that previous reports 
have demonstrated high affinity binding of TR2 on all the direct repeat elements ranging 
from DR1 to DR6 including RARE (18, 20, 24). Moreover, TRR also failed to bind 
RARE (data not shown) and therefore RARE was used as a nonspecific competitor in 
the competition assays. Taken together, these results demonstrate that TRR shows a 
considerably different binding pattern despite having a 95% sequence identity in DBD 
and identical P box and D box motif with TR2. Based on these results, we assume that 
the sequence identity in the DBD may not be the only criterion for DNA recognition and 
binding specificity of TRR, and we cannot rule out the possibility that other domains 
may have definite roles in DNA binding. In consistence with the gel shift results using 
cannonical direct repeat sequences TRR formed specific complexes with a DR-4 motif 
located in phenobarbital-responsive enhancer units (PBRU) from the 5'-flanking region 
of the chicken drug-inducible cytochrome P450 CYP2H1 (Fig. 4B). These DR-4 motifs 
have been shown to be crucial for mediating drug-induction of these enhancer elements 
(27, 33). RXR alone does bind to the PBRUs (lane 2) whereas, TRR forms a 
homodimeric complex with the probes (lane 3) that is not influenced by addition of 
RXR (lane 4) or RXR and anti-RXR antibody (lane 5). As control, CXR/RXR 
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heterodimers bind to the more proximal 264-bp PBRU (left blot) and the distal 240-bp 
PBRU (right blot) as described elsewhere (27,). 
 
TRR forms homodimers  
 Since TRR shares an identical 9th heptad sequence with all TR2 family 
members, we attempted to examine the interaction pattern of TRR. As expected, TRR 
formed homodimeric complex in the yeast two hybrid interaction assay and activated 
the LexA response element driven -galactosidase reporter gene in the presence of both 
LexA-TRR and B42-TRR (Fig. 5A). However, TRR failed to interact with RAR or 
RXR and co-factors NcoR and SMRT. To confirm the homodimerization activity of 
TRR in vivo, a mammalian two hybrid approach was used. The LBD of TRR was 
cloned in a CMV promoter driven mammalian expression vector containing GAL4 
DBD and also in a vector encoding VP16 activation domain. Transient transfection 
assays were performed in HeLa cells, using a GAL4-dependent luciferase reporter gene. 
Upon co-transfection, GAL4-TRR-LBD interacted with VP16-TRR-LBD and thus 
activated the reporter activity significantly (Fig. 5B). However, GAL4-TRR-LBD alone 
strongly repressed the basal reporter activity, indicating that TRR behaves as other 
liganded receptors, which show repressive activity in the absence of ligand. Taken 
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together, these results clearly demonstrated that TRR exerts its biological effect in the 
form of a homodimer. This phenomenon is typical in TR2 subfamily of receptors, which 
are not shown to form heterodimeric complex with RXR despite bearing an identical 
heptad repeat in the helix 10 with RXR.  However, it remains to be determined 
whether TRR can interact with the known TR2 interacting proteins such as RIP140 and 
TR4 (34, 35). 
 
TRR shows transcriptional activity  
Previous studies demonstrated the biological activity of TR2 to be primarily 
repressive on both RA induction of DR1 and DR5 elements, and T3 induction of DR4 
elements. Previous reports have also shown that the DBD and LBD of TR2 are 
sufficient for this repressive action (18, 21, 24). To investigate the effect of TRR on the 
elements it binds, transient transfection studies were carried out in HeLa cells. 
Interestingly, TRR alone was sufficient for the activation of the elements DR1, DR4, 
and DR5 ((Fig.6), while it did not show any transcriptional activity on a minimal TK-
luc element  (data not shown), thus confirming the activation of the DR1, DR4 and 
DR5 by TRR to be a specific activity which is dependent on DNA binding. These 
results clearly suggest that TRR is an active orphan nuclear receptor and this receptor 
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might be a more potent transcriptional activator than its mammalian relatives. However, 
as demonstrated in Fig. 5B, GAL4-TRR-LBD repressed the basal promoter activity of 
GAL4TK-Luc, we assumed the LBD and specially the AF-2 may not be the domain in 
TRR responsible for this transcriptional activity. Since all the TR2 family members 
show a remarkable identity in the otherwise hypervariable N-terminal region we 
assumed this region might be important for TRR transcriptional activity. To investigate 
this possibility a GAL4DBD fused TRR A/B domain representing the amino acids 1 to 
74 or GAL4DBD fused TRRLBD were transfected in HeLa cells. Whereas TRRLBD 
repressed the basal promoter activity, the A/B domain showed a significant 
transcriptional activity, thereby activating the promoter in a dose-dependent manner 
(Fig. 7). These results indicate that TRR A/B domain may contain a ligand independent 
activation function. However, we can not rule out the possibility that a yet unidentified 
ligand exists for TRR which is needed for the complete transcriptional activity of this 
















Here, we describe the isolation and characterization of a novel avian orphan 
nuclear receptor called TRR, which appears to belong to the TR2 subfamily of orphans 
as it bears highest amino acid identity with TR2. Analysis of the TRR sequence suggests 
that TRR may not be an orthologue of mammalian TR2. First, the overall identity 
between TR2 and TRR is only 72%. The A/B domain bears 40% identity, and the ligand 
binding domain bears 75% identity with TR2 (Fig. 1B), whereas human and chicken 
COUP-TFIIs bear an overall identity of 93% and a 99% identity with the LBD. 
Moreover, the difference in expression pattern and DNA binding properties also support 
the idea that TRR is different from TR2 in its structure and function. 
A critical analysis of TRR structure demonstrated many interesting differences 
of this receptor with its mammalian relative TR2. A closer examination of the hyper-
variable A/B domain showed that the first 19 amino acids in TRR were remarkably 
identical to both TR2 and its amphibian relative DOR1 (Fig. 2A), indicating that this 
region might play a very important role in the biological functions of this group of 
receptors. However, the minimal sequence of TR2 implicated in the activation function 
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of TR2, spanning from N-terminal amino acid 25-30 (26) was not found to exist in TRR 
or DOR1. Moreover, the amino acids from position 50-100, which had been previously 
implied to have a masking affect on the transcriptional activity of TR2 (26) were not 
conserved in TRR. Interestingly, TRR showed a gap of 17 amino acids from amino acid 
numbered 52, and these amino acids were interestingly found to be conserved in both 
human and mouse TR2 and DOR1. However, the LBD of TRR showed a striking 
homology with TR2 in the heptad repeat in the helix 10 (Fig. 2B), indicating that 
dimerization properties of the two receptors might be identical. Moreover, a critical 
comparative analysis of the LBD revealed that a conserved basic amino acid residue in 
the “signature motif”, arginine or lysine in all the nuclear hormone receptors with the 
exception of NGFIB which contains a glutamic acid instead, was substituted by a 
hydrophobic residue (leucine) in TR2.  In contrast, this basic residue was conserved in 
both TRR (Fig. 1A), and DOR1. This observation indicates that the leucine residue 
observed in all the mammalian homologs of TR2 might have originated later in  
evolution. Based on these structural analyses we suggest that TRR may have originated 
as a separate lineage in the course of evolution and attained very specialized structural 
as well as biological parameters and properties. Our hypothesis is also duly supported 
by the fact that tissue distribution of TRR shows a marked difference from its 
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mammalian and amphibian relatives.  
High expression of an approximately 2.4 kb transcript of TRR was observed in lung, 
testis, kidney and small intestine (Fig. 3A), whereas TR2 expression is confined to mid 
gestation embryonic stages and adult testis only (11). The expression pattern clearly 
suggests that the role of TRR might be much different from TR2. Surprisingly, TRR was 
found to be expressed in all the embryonic stages examined (Fig. 3B), and the 
expression seems to increase at  about stage 26 onwards when rapid development of 
alimentary tract and other visceral organs takes place (44), and the intensity of 
expression remains constant in stage 28 in both head and trunk segments indicating that 
TRR may play an important role in overall organogenesis. however, detail expression 
analysis for TRR in a wider range of embryonic stages as well as its localization in 
different embryonic tissues is required to fully understand the role of TRR in chicken 
emryonic development, and such studies are currently on going in our laboratory.  
 
DNA binding analysis demonstrated that TRR binds efficiently to DR1, DR4, 
and DR5. In consistence with the gel mobility shift assay results with cannonical DR 
series sequences TRR also formed specific homodimeric complex on the DR4 motif of 
two distinct PBRUs, although the, binding affinity for TRR on these elements was lower 
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than CXR-RXR heterodimer, but this receptor did not show any specific binding 
activity to DR0 or DR2 (Fig. 4A and 4B). Moreover, TRR showed little or no binding 
activity to other members of DR elements such as DR3, DR6 and RARE (data not 
shown). Previous studies have demonstrated that TR2 can bind all of the direct repeat 
elements ranging from DR1 to DR6 in the following order of affinity: DR1 > DR2 > 
DR5, DR4, DR6 > DR3 (18). This was highly surprising considering the fact that TRR 
bears 95% amino acid identity with TR-2 in the DBD. Interestingly, a similar 
phenomenon has also been observed in the case of estrogen receptor (ER)  and . ER 
efficiently binds a consensus steroidogenesis factor 1 response element (SFRE), but 
ER fails to bind it in spite of an almost identical DBD differing by two amino acids 
only (39). Based on this result, we suggest that DNA recognition and binding specificity 
of nuclear receptors may be determined not only by the P box of DBD but also by other 
domains particularly the LBD. Our view is also supported by a previous observation in 
which substitutive mutation of conserved glutamic acid residues at amino acid 
numbered 553 and 554 in the LBD of TR2 drastically changed the DNA binding affinity 
of the receptor (24). 
Both in vitro and in vivo interaction studies with the TRR LBD demonstrate 
that TRR can form homodimers, and this receptor did not show any interaction with 
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RXR, which is a common heterodimerization partner of many receptors (Fig. 5A and 
5B). Interestingly, members of the TR2 subfamily of receptors are structurally very 
close to RXR subfamily members and they share an almost identical heptad repeat in 
the helix 10 region which is believed to be an essential region for dimerization 
properties of nuclear hormone receptors. Thus it remains an interesting question why 
TR2 family members do not share similar dimerization properties with RXR. TRR LBD 
did not show any interaction with RAR or cofactors like NCOR, and SMRT. In fact, a 
wide array of nuclear hormone receptors including, ER, GR, VDR, T3R, ERR, mCAR, 
SHP, DAX-1, SF-1 and cofactors like SRC-1 and CBP/P300 were tested for interaction 
with TRR LBD (data not shown) but we did not observe any interaction of TRR with 
these proteins.  However, it remains to be determined whether TRR can interact with 
the known TR2 interacting proteins, like TR4 and RIP-140 (34, 35). It also remains to 
tested whether the A/B domain of TRR can interact with proteins involved in the basal 
transcriptional machinery or with transcriptional cofactors.  
 
Transient transfection studies revealed that TRR efficiently transactivates DR1, 
DR4 and DR5 DNA recognition elements ((Fig. 6), whereas, TR-2, was found to be 
primarily repressive on most of the elements tested, and it was transcriptionally active 
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only in the context of the specific promoter of RAR2 (26). This contrast in the 
behavior of TR2 and TRR indicates that TRR might act as a more potent transcriptional 
activator of its putative targets than TR-2. This hypothesis also gains support from the 
fact that TRR could not repress T3 or RA induced activity of DR1, DR4, and DR5 
elements (data not shown). Although TRR binds to the 264bp and 240bp CYP2H1 
PBRUs (Fig. 4B), we could not observe an effect of TRR on drug induction mediated by 
these elements. In CV-1 transactivation assays, TRR could neither be activated by 
prototypical inducers, such as phenobarbital, propylisopropylacetamide, dexamethasone, 
metyrapone, -naphtoflavone, clotrimazol or rifampicin nor was any repressing effect 
on the extent of induction mediated by chicken xenosensing receptor CXR found (data 
not shown). These findings are corroborated further by experiments in the drug-
responsive chicken hepatoma cell line LMH, where transfection of TRR did not 
influence drug response as measured by reporter gene (data not shown). Therefore, 
binding of the CXR/RXR heterodimer is dominant over TRR binding which is also 
evident from gel mobility shift asaays performed with two different chicken PBRUs as 
probes (Fig. 4B). Nevertheless, further investigations will have to be done to examine 
the role of TRR in hepatic drug-induction of cytochromes P450. 
 Interestingly, the LBD of TRR showed a repressive activity, which was 
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transferable to a heterologus protein (GAL4DBD), indicating either the AF-2 region is 
silent or a specific ligand is needed for its activity. However, a potent ligand 
independent activation function was found in the N-terminal 72 amino acids which 
could confer its transcriptional activity to a GAL4DBD (Fig. 7), indicating that the 
silent AF-2 may not be sufficient to mask this activity. In contrast to TR2, in which the 
activation function was found to exist in the N-terminal amino acids 10-30, and 
particularly the amino acids 25-30 which were found to be the most important region for 
the activation function of TR2, those amino acids were not conserved in TRR. Moreover, 
the amino acids 50-138 in TR2, which were described to have a masking effect on the 
AF-1 activity, were also not conserved in TRR. However, it was highly interesting to 
note that the amino acids 1-19 were remarkably conserved in all the TR-2 family 
members indicating that this region might play an important role in the transcriptional 
activity. We also assume that it’s perhaps due to the absence of any masking region in 
the A/B domain of TRR, this receptor showed significant transcriptional activity on all 
its recognition elements. This view is in consistence with a previous report (26) where 
the full A/B domain of TR-2 did not show any transcriptional activity. However, it 
remains important to map the activation function in TRR as well as finding the specific 
transcriptional co-factors, which might interact with this region, and such studies are 
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currently being pursued in our laboratory. Finally, to identify the possible ligand for 
TRR, several potential activators for nuclear receptors were tested using either full 
length TRR on DR1-Luc reporter element or GAL4TRR LBD using a GAS-Luc 
reporter construct, but no significant activation of TRR was observed, indicating that a 
specific and yet unidentified ligand might be required for the AF-2 domain of TRR to be 
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Fig. 1.  Structure and sequence of TRR. (A)  Nucleotide and the deduced amino 
acid sequence of TRR clone. The 5’ and 3’ non coding regions are shown, and the 
complete coding region of TRR is shown with its amino acid sequence. The DNA 
binding domain is underlined and signature motif in LBD is indicated with shaded box. 
(B) Schematic representation of TRR protein and comparison with other members of 
nuclear receptor superfamily. The positions of putative initiation and terminations are 
indicated as a number, the A/B domain, C domain and DEF regions are indicated. The 
percentage of amino acid identity in each relevant region between TRR and other 
orphans was determined using domain by domain allignment with Macvector software 
from Macintosh. 
 
Fig. 2. Sturctural comparison between TRR and other members of the nuclear 
hormone receptor superfamily. (A) Comparison of the N-terminal sequence of TRR, 
mTR2, hTR2, and DOR-1. The N-terminal sequence of TRR orphan nuclear receptor 
and other close relatives were aligned, the conserved first 19 amino acids are marked by 
an overhead bar.  Dashes (---) represent the gaps included for the appropriate 
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alignment. Asteriks (*) represent identical amino acids and the dots (.) represent amino 
acids similar in chemical properties. (B) A summary of the C-terminal amino acid 
sequences of TRR, hTR2, mTR4 and cRXR. The C-terminal sequence of TRR and 
other close relatives were aligned, the conserved 9th heptad repeat and the putative AF2 
are in bold, and are marked with overhead bar. The conserved glutamic acid residues are 
shaded in gray, and the helix 10, 11, and 12 regions are underlined. Dashes (--) represent 
the gaps included for the appropriate alignment.  
 
Fig 3. Tissue distribution and expression of TRR. (A) Tissue distribution of TRR. A 
Northern blot was prepared by using approximately 30 g total RNA extracted from the 
indicated tissues of an adult broiler breeder, and hybridized with full length TRR 
cDNA. The arrows indicate the positions of 28S and 18S ribosomal RNA. The lower 
panel represents 28S ribosomal RNA as a loading control. (B) An embryo stage blot 
was prepared using approximately 30g of total RNA prepared from indicated 
embryonic stages (31), and hybridized with a full length TRR cDNA probe. The lower 
panel represents 28S ribosomal RNA as a loading control. (C) SDS-PAGE analysis of 
in vitro translated TRR. Full length TRR in pBluescript was in vitro translated and 
loaded on a 12% polyacrylamide denaturing gel. The numbers on the left denote the 
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molecular weight marker in kDa, and the arrow on the right denotes the position of the 
protein band. 
 
Fig 4. Binding analysis of TRR. (A) A gel shift analysis was performed using in vitro 
translated TRR protein with end labeled direct repeat DNA sequences spaced by 0, 1, 2, 
4, and 5 base pairs (DR0, DR1, DR2, DR4, DR5). Lanes indicated as L; unprogrammed 
lysate only, P; in vitro synthesized TRR only, SC; specific competition using 50 fold 
molar excess of cold probe, NC; nonspecific competition using 50 fold molar excess of 
unlabeled nonspecific DNA. The arrow on the left hand side indicates specific protein-
DNA complex, and ** indicates nonspecific complexes..  (B) Radiolabeled 264-bp 
PBRU (left blot) (27) and 240-bp PBRU (right blot) (28) were incubated with in vitro 
transcribed/translated chicken RXRgamma (lanes 2, 4, 5 and 6), TRR (lanes 3, 4 and 5), 
chicken CXR (lane 6), anti-RXR antibody (lane 5) or mock programmed lysate (lane 1). 
The black arrows depict complexes of homodimerized TRR and the probe whereas the 
gray arrows indicate complexes of CXR/RXR heterodimers with the probe resulting in 
shifts. 
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Figure 5. TRR forms a homodimer both in vitro and in vivo. (A) TRR forms 
homodimer in vitro. A yeast strain EGY418 which contains an integrated  
galactosidase reporter gene controlled by LexA binding sites was transformed with 
PEG202-TRR LBD encoding LexADBD/TRR LBD, and PEGJ4-5-RAR, RXR, NcoR, 
SMRT or TRR LBD encoding B42AD/RAR, RXR, NcoR, SMRT or TRRLBD. The 
transformants were selected on plates containing appropriate markers and assayed for -
galactosidase activity. LexAN and B42N represent respective empty vectors used as a 
negative control. (B) TRR forms homodimer in vivo. 0.2 g of pcDNA3 GAL4TRR 
encoding GAL4DBD/TRR and 0.2 g of pcDNA3 VP16TRR encoding VP16AD/TRR 
were transiently transfected to HeLa cells, with 0.4 g of GAL4-TK LUC. GAL4 N and 
VP16 N are empty vectors used as negative controls. The luciferase activity was 
measured and normalized against -galactosidase activity. One representative result is 
shown, similar results were obtained with at least three independent experiments. 
 
 
Fig.6 TRR specifically activates canonical DR1, DR4 and DR5 elements. HeLa cells 
were co-transfected with canonical DR1 (A), DR4 (B), and DR5 (C) element driven 
luciferase reporter constructs with 0 (mock)100, 200 or 500ng of pcDNA3 TRR as 
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indicated in the figure. The luciferase activity was measured and normalized against the 
-galactosidase activity. The result shown is the mean of three independent experiments 
and the error bars indicate the standard deviation. Similar results were also obtained 
from co-transfection experiments in CV-1 cells. 
 
Fig.7 A/B domain of TRR shows constitutive transcriptional activity. HeLa cells 
were co-transfected with a 5 copy GAS-luc promoter and indicated doses of GAL4-
TRRLBD or GAL4-TRRA/B as indicated in the figure. The luciferase activity was 
measured and normalized against the -galactosidase activity. One representative result 
is shown, similar results were obtained with at least three independent experiments, and 
the result was also reproducible in CV-1cells. 
 
 
 
 








